Zebrafish as a Model for Cardiovascular and Metabolic Disease: The Future of Precision Medicine

Ramcharan Singh Angom,Naga Malleswara Rao Nakka

DOI: https://doi.org/10.3390/biomedicines12030693

IF: 4.757

2024-03-20

Biomedicines

Abstract:The zebrafish (Danio rerio) has emerged as an appreciated and versatile model organism for studying cardiovascular and metabolic diseases, offering unique advantages for both basic research and drug discovery. The genetic conservation between zebrafish and humans and their high fecundity and transparent embryos allow for efficient large-scale genetic and drug-oriented screening studies. Zebrafish possess a simplified cardiovascular system that shares similarities with mammals, making them particularly suitable for modeling various aspects of heart development, function, and disease. The transparency of zebrafish embryos enables the real-time visualization of cardiovascular dynamics, offering insights into early embryonic events and facilitating the study of heart-related anomalies. In metabolic research, zebrafish provide a cost-effective platform for modeling obesity, type 2 diabetes, hyperlipidemia, and other metabolic disorders. Their high reproductive rate allows for the generation of large cohorts for robust statistical analyses, while advanced genetic tools, such as CRISPR/Cas9, enable precise gene editing with which to model specific genetic mutations associated with human diseases. Zebrafish metabolic models have been instrumental in elucidating the molecular mechanisms underlying metabolic diseases, studying the effects of environmental factors, and identifying potential therapeutic targets. Additionally, the permeability of zebrafish embryos to small molecules facilitates drug discovery and screening, offering a rapid and economical approach to identifying compounds with therapeutic potential. In conclusion, zebrafish cardiovascular and metabolic disease models continue to contribute significantly to our perception of disease pathogenesis, providing a platform for translational research and developing novel therapeutic interventions. The versatility, scalability, and genetic manipulability of zebrafish position them as an invaluable asset in unraveling the complexities of cardiovascular and metabolic diseases. This review presents an overview of the zebrafish model's key features and contributions to investigating cardiovascular and metabolic disorders. We discuss the benefits and drawbacks of using zebrafish models to study human disease and the critical findings revealed by the progress in this endeavor to date.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The paper primarily explores the application of zebrafish (Danio rerio) as a model for cardiovascular and metabolic disease research and its future potential in precision medicine. Specifically, the paper aims to address the following key issues:

1. **Genetic Conservatism and Transparency**: Zebrafish share a high degree of genetic similarity with humans in terms of cardiovascular development and function. The high transparency of zebrafish embryos during early development allows researchers to observe the development of the heart and blood vessels in real-time, thereby gaining a deeper understanding of the molecular and cellular mechanisms of cardiovascular diseases.

2. **High Reproductive Rate**: The high reproductive capacity of zebrafish makes large-scale genetic and drug screening possible. The large number of embryos helps to explore the impact of various genetic and environmental factors on cardiovascular health and promotes the discovery of new therapeutic targets.

3. **Conserved Cardiovascular Physiology**: Zebrafish possess a cardiovascular system similar to that of mammals, with a two-chambered heart structure akin to the early developmental stages of the human heart. This makes zebrafish an ideal model for studying fundamental cardiovascular processes such as heart development, contractility, and angiogenesis.

4. **Ease of Genetic Manipulation**: Advanced genetic tools (such as Zinc Finger Nucleases [ZFN], Transcription Activator-Like Effector Nucleases [TALEN], and CRISPR/Cas9) make targeted gene modification in zebrafish relatively simple. This ease of genetic manipulation allows researchers to model specific cardiovascular diseases, study the effects of gene mutations, and identify potential therapeutic targets.

5. **Drug Discovery and Toxicity Screening**: The permeability of zebrafish to small molecules makes them suitable for drug delivery. Combined with easily monitored cardiac functions, the zebrafish model aids in efficient drug discovery and toxicity screening, supporting the preclinical evaluation of candidate drugs for cardiovascular diseases.

Through these advantages, the zebrafish model plays a crucial role in the research of cardiovascular and metabolic diseases, providing a robust platform for understanding disease mechanisms and developing new therapeutic approaches. Additionally, zebrafish are used to study heart regeneration mechanisms, particularly in the repair process following myocardial infarction. The unique ability of zebrafish in heart regeneration makes them an important model for exploring the process of cardiac tissue regeneration.